Juvenile dermatomyositis in the nice area: A retrospective study 1991-2001;Dermatomyosite juvénile dans la région niçoise etude rétrospective 1991-2001

Annales de Dermatologie et de Venereologie

Volumn 129, Issue 10 I, 2002, Pages 1120-1124

  Jager C ^a   Sirvent, N ^a   Rabasse, N ^a   Soler, C ^b   Sebag, F ^c   Boutte, P ^a   Lacour, J P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Fondation Lenval Hopital pour Enfants   (France)

^c Centre Hospitalier General   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; MUSCLE ENZYME;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; FEMALE; FOLLOW UP; FRANCE; HUMAN; IMMUNOTHERAPY; JUVENILE; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SKIN DEFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; BIOPSY; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036808747     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bohan A, Peter JB. Polymyositis, and dermatomyositis. N Engl J Med 1975;292:344-7.
2. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993;100:116S-23S.
3. Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA. Polymyositis and dermatomyositis in children: An epidemiologic and clinical comparative analysis. J Rheumatol 1982;9:390-4.
4. Peloro T. M, Miller OF 3rd, Hahn TF, Newman ED. Juvenile dermatomyositis: A retrospective review of a 30-year experience. J Am Acad Dermatol 2001;45:28-34.
5. Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998;25:1198-204.
6. Fernandez-Sola J, Casademont PJ, Grau JM, Graus F, Cardellach F, Pedrol E et al. Normal creatine kinase activity in idiopathic inflammatory myopathy: Does it have prognostic implications ? J Rheumatol 1991;18: 1640-1.
7. Park JH, Olsen NJ, King L Jr, Vital T, Buse R, Kari S et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995;38:68-77.
8. King LE Jr, Park JH, Adams L, Vital T, Olsen NJ. Evaluation of muscles in a malade with suspected amyopathic dermatomyositis by magnetic resonance imaging and phosphorus-31-spectroscopy. J Am Acad Dermatol 1994;30:137-8.
9. Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR et al. Magnetic Resonance Imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of malades with dermatomyositis. Arthritis Rheum 1994;37: 736-46.
10. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: A review. J Invest Dermatol 1993;100:124S-7S
11. Haustein UF. Amyopathic dermatomyositis (dermatomyositis sine myositis) and cutaneous dermatomyositis with mild muscle disease. J Eur Acad Dermatol Venereol 1995;4:30-4.
12. Wedgwood RJ, Cook CD, Cohen J. Dermatomyositis: report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics 1953;12:447-66.
13. Huang JL. Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy. Clin Exp Rheumatol 1999;17:621-4.
14. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman R. Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy prevents calcinosis and shortens disease c6urse in juvenile dermatomyositis (JDMS). Arthritis Rheum 1994;37: R10 (abstract).
15. Prieur AM. Dermatomyosites. In: Prieur AM, eds. Rhumatologie Pédiatrique. Paris: Flammarion, 1999.
16. Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 1991;91: 169-72.
17. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
18. Göttfried I, Seeber A, Aregg B, Rieger A, Stingl G, Volc-Platzer B. High dose intravenous immunglobulin (IVIG) in dermatomyositis: Clinical responses and effect on sIL-2R levels. Eur J Dermatol 2000;10:29-35.
19. Collet E, Dalac S, Maerens B, Coyrtois JM, Izac M, Lambert D. Juvenile dermatomyositis: Treatment with intravenous gammaglobulin. Br J Dermatol 1994;130:231-4.
20. Basta M, Dalakas MC. High dose intravenous immunoglobulin exerts its benefical effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994;94: 1729-35.
21. Amemiya K, Semino-Mora C, Granger RP, Dalakas MC. Downregulation of TGF-beta1 mRNA and protein in the muscle of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin Immunol 2000;94;99-104.
22. Cherin P, Pierre JC, Wechsler B, Bletry O, Ziza JM, Laraki R et al. Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: A report of 11 cases. J Rheumatol, 1994;21:1092-7.
23. Al-Mayouf S, Al-Mazyed A, Bahabri S. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol 2000;19:138-41.
24. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: Prediction and treatment with cyclosporine. J Rheumatol 1999;26:1527-33.
25. Gomez-Mora M, Guzman J, Rodriguez-Suarez RS. Early cytotoxic therapy for children with juvenile dermatomyositis. Arthritis Rheum 1995;38:S231 (abstract).
26. Olson NY, Lindsley CB. Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 1989;21:2171-227.
27. Person DA. Juvenile dermatomyositis. Pediatrics 1999;103:194-5.
28. Eisenstein DM, Paller AS, Pachman LM. Juvenile dermatomyositis presenting with rash alone. Pediatrics 1997;100:391-2.